Concepedia

Sayantan Chakraborty

SC

Statistics

Publications

5

Citations

213

H-Index

5

Active since

2015

Affiliations

Indian Institute of Chemical Biology(Current)

Tata Medical Center

College of Medicine & Sagore Dutta Hospital

National Institute on Aging

Institute of Genomics and Integrative Biology

Sayantan Chakraborty is an author at Indian Institute of Chemical Biology specializing in immunotherapy, clinical trials, and humoral immunity.

ORCID

Top concepts

Publications per year

2015–2022

5

Publications

5

Ezh2 Regulates Activation-Induced CD8+ T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression

Guobing Chen, Kalpana Subedi, Sayantan Chakraborty et al. · Frontiers in Immunology · 2018 · 59 citations · Full text

Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial

Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay et al. · 2020 · 58 citations · Full text

, , +17

A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay et al. · Nature Communications · 2022 · 40 citations · Full text

Engulfment pathways promote programmed cell death by enhancing the unequal segregation of apoptotic potential

Sayantan Chakraborty, Eric J. Lambie, Samik Bindu et al. · Nature Communications · 2015 · 39 citations · Full text

Hedgehog dysregulation contributes to tissue-specific inflammaging of resident macrophages

Mahamat Babagana, Kyu‐Seon Oh, Sayantan Chakraborty et al. · Aging · 2021 · 17 citations · Full text

1–5 of 5